Clovis Oncology (NASDAQ:CLVS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Clovis Oncology beat estimated earnings by 14.29%, reporting an EPS of $-0.48 versus an estimate of $-0.56.
Revenue was up $7.33 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 2.56% drop in the share price the next day.
Here’s a look at Clovis Oncology’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.48 | -0.56 | -0.72 | -0.77 |
| EPS Actual | -0.56 | -0.59 | -0.64 | -0.74 |
| Revenue Estimate | 39.09M | 41.12M | 44.55M | 43.22M |
| Revenue Actual | 37.92M | 36.82M | 38.05M | 43.30M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
